RESUMEN
Three case reports of Cytomegalovirus (CMV) disease in seronegative renal transplant recipients of seropositive donor kidneys are presented. Clinicians need to have a high index of suspicion for CMV disease in such patients. Early diagnosis and treatment are essential to decrease morbidity and mortality. Prophylaxis with antiviral and/or CMV-hyperimmunoglobulin may decrease the incidence of serious infection.
Asunto(s)
Infección Hospitalaria/transmisión , Infecciones por Citomegalovirus/transmisión , Trasplante de Riñón/efectos adversos , Adolescente , Adulto , Infección Hospitalaria/sangre , Infección Hospitalaria/tratamiento farmacológico , Infecciones por Citomegalovirus/sangre , Infecciones por Citomegalovirus/tratamiento farmacológico , Diagnóstico Diferencial , Femenino , Ganciclovir/uso terapéutico , Humanos , MasculinoRESUMEN
Three case reports of cytomegalovirus (CMV) disease in seronegative renal transplant recipients of seropositive donor kidneys are presented. Clinicians need to have a high index of suspicion for CMV disease in such patients. Early diagnosis and treatment are essential to decrease morbidity and mortalitiy. Prophylaxis with antiviral and/or CMV-hyperimmunoglobulin may decrease the incidence of serious infection (AU)
Asunto(s)
Informes de Casos , Humanos , Masculino , Femenino , Adolescente , Adulto , Trasplante de Riñón/efectos adversos , Infecciones por Citomegalovirus/complicaciones , Infecciones por Citomegalovirus/tratamiento farmacológico , Terapia de Inmunosupresión/efectos adversos , Rechazo de InjertoRESUMEN
Three case reports of cytomegalovirus (CMV) disease in seronegative renal transplant recipients of seropossitive donor kidneys are presented. Clinicians need to have a high index of suspicion for CMV disease in such patients. Early diagnosis and treatment are essential to decrease morbidity and mortalitiy. Prophylaxis with antiviral and/or CMV-hyperimmunoglobulin may decrease the incidence of serious infection